These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24084491)

  • 21. Triggering germination represents a novel strategy to enhance killing of Clostridium difficile spores.
    Nerandzic MM; Donskey CJ
    PLoS One; 2010 Aug; 5(8):e12285. PubMed ID: 20808871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.
    Luna RA; Boyanton BL; Mehta S; Courtney EM; Webb CR; Revell PA; Versalovic J
    J Clin Microbiol; 2011 Mar; 49(3):851-7. PubMed ID: 21209161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oscillating behavior of Clostridium difficile Min proteins in Bacillus subtilis.
    Makroczyová J; Jamroškovič J; Krascsenitsová E; Labajová N; Barák I
    Microbiologyopen; 2016 Jun; 5(3):387-401. PubMed ID: 26817670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Revised Understanding of Clostridioides difficile Spore Germination.
    Lawler AJ; Lambert PA; Worthington T
    Trends Microbiol; 2020 Sep; 28(9):744-752. PubMed ID: 32781028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function σ factors in Clostridium difficile.
    Ho TD; Ellermeier CD
    Infect Immun; 2011 Aug; 79(8):3229-38. PubMed ID: 21628514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
    Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory maintenance of Clostridium difficile.
    Sorg JA; Dineen SS
    Curr Protoc Microbiol; 2009 Feb; Chapter 9():Unit9A.1. PubMed ID: 19235151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of operating conditions on the persistence of E. coli, enterococci, Clostridium perfringens and Clostridioides difficile in semi-continuous mesophilic anaerobic reactors.
    Lorine D; Céline D; Caroline LM; Frédéric B; Lorette H; Julie B; Laure M; Christine Z; Typhaine P; Sandra R; Emmanuelle H; Rabab SZ; Jeanne C; Anne-Marie P
    Waste Manag; 2021 Oct; 134():32-41. PubMed ID: 34403994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.
    Lynch T; Chong P; Zhang J; Hizon R; Du T; Graham MR; Beniac DR; Booth TF; Kibsey P; Miller M; Gravel D; Mulvey MR;
    PLoS One; 2013; 8(1):e53757. PubMed ID: 23349739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.
    Pokhrel A; Poudel A; Castro KB; Celestine MJ; Oludiran A; Rinehold AJ; Resek AM; Mhanna MA; Purcell EB
    J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB.
    Curry SR; Schlackman JL; Hamilton TM; Henderson TK; Brown NT; Marsh JW; Shutt KA; Brooks MM; Pasculle AW; Muto CA; Harrison LH
    J Clin Microbiol; 2011 Nov; 49(11):3788-93. PubMed ID: 21880961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the difficulties of isolating Clostridium difficile from hospital environments.
    Malik DJ; Patel KV; Clokie MR; Shama G
    J Hosp Infect; 2013 Jun; 84(2):181-3. PubMed ID: 23643391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic Labeling of Clostridioides difficile Proteins.
    Trautwein-Schult A; Bartel J; Maaß S; Becher D
    Methods Mol Biol; 2021; 2228():271-282. PubMed ID: 33950497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
    Nistico JA; Hage JE; Schoch PE; Cunha BA
    Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.
    Jump RL; Li Y; Pultz MJ; Kypriotakis G; Donskey CJ
    Antimicrob Agents Chemother; 2011 Feb; 55(2):546-9. PubMed ID: 21135181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile.
    Gebhart D; Williams SR; Bishop-Lilly KA; Govoni GR; Willner KM; Butani A; Sozhamannan S; Martin D; Fortier LC; Scholl D
    J Bacteriol; 2012 Nov; 194(22):6240-7. PubMed ID: 22984261
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Jenior ML; Leslie JL; Young VB; Schloss PD
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic manipulation of Clostridium difficile.
    Bouillaut L; McBride SM; Sorg JA
    Curr Protoc Microbiol; 2011 Feb; Chapter 9():Unit 9A.2. PubMed ID: 21400677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of Markerless Deletions in the Nosocomial Pathogen
    Theophilou ES; Vohra P; Gallagher MP; Poxton IR; Blakely GW
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.